Table 1.
Case | Age | Sex | Biopsy | T&F R | T&FL | Tsys R | Tsys L | TSS R | TSS L | OSDI |
---|---|---|---|---|---|---|---|---|---|---|
1 | 71 | F | Positive* | IIB | IIB | 15 | 13 | 8 | 6 | 40 |
2 | 48 | F | Positive | IIB IIIA | IIB IIIA | 9 | 27 | 5 | 5 | 70 |
3 | 65 | F | Positive | IIC | IIB | 14 | 14 | 12 | 10 | 68 |
4 | 65 | M | Positive | I | I | 13 | 12 | 6 | 4 | 40 |
5 | 34 | M | Positive | IIA | IIB | 7 | 7 | 7 | 6 | 40 |
6 | 68 | F | Positive | IIB IIIB | IIB IIIB | 7 | 10 | 12 | 12 | 69 |
7 | 82 | M | Positive | IIC IIIC | IIB IIIC | 11 | 13 | 8 | 7 | 50 |
8 | 74 | F | Positive | IIB IIIC | IIB IIIB | 12 | 11 | 8 | 4 | 25 |
T&F, Tauber and Foster classification; R, right eye; L, left eye; Tsys, total symptoms score; TSS, total sign score; OSDI, Ocular Surface Disease Index questionnaire; T.T., topical therapy; Positive: lymphoplasmacellular infiltrates; Positive*, lymphoplasmacellular infiltrates and DIF positivity